Roble Belko & Company’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$30K	Hold	433	–	–	﹤0.01%	208
2025 Q1	$30K	Hold	433	–	–	﹤0.01%	201
2024 Q4	$37K	Hold	433	–	–	0.01%	185
2024 Q3	$52K	Buy	433 +1	+0.2%	+$120	0.01%	165
2024 Q2	$62K	Hold	432	–	–	0.01%	160
2024 Q1	$55K	Buy	432 +6	+1%	+$764	0.01%	169
2023 Q4	$44K	Hold	426	–	–	0.01%	166
2023 Q3	$39K	Buy	426 +4	+0.9%	+$366	0.01%	154
2023 Q2	$34K	Hold	422	–	–	0.01%	159
2023 Q1	$34K	Hold	422	–	–	0.01%	168
2022 Q4	$29K	Hold	422	–	–	0.01%	186
2022 Q3	$21K	Hold	422	–	–	0.01%	195
2022 Q2	$24K	Hold	422	–	–	0.01%	187
2022 Q1	$23K	Hold	422	–	–	﹤0.01%	225
2021 Q4	$24K	Hold	422	–	–	﹤0.01%	203
2021 Q3	$20K	Hold	422	–	–	﹤0.01%	206
2021 Q2	$18K	Hold	422	–	–	﹤0.01%	226
2021 Q1	$14K	Hold	422	–	–	﹤0.01%	237
2020 Q4	$15K	Hold	422	–	–	﹤0.01%	212
2020 Q3	$15K	Hold	422	–	–	﹤0.01%	207
2020 Q2	$14K	Hold	422	–	–	﹤0.01%	223
2020 Q1	$13K	Hold	422	–	–	﹤0.01%	227
2019 Q4	$12K	Hold	422	–	–	﹤0.01%	251
2019 Q3	$11K	Hold	422	–	–	﹤0.01%	253
2019 Q2	$11K	Hold	422	–	–	﹤0.01%	250
2019 Q1	$11K	Hold	422	–	–	﹤0.01%	219
2018 Q4	$10K	Hold	422	–	–	﹤0.01%	209
2018 Q3	$10K	Hold	422	–	–	﹤0.01%	224
2018 Q2	$10K	Hold	422	–	–	﹤0.01%	229
2018 Q1	$10K	Hold	422	–	–	﹤0.01%	234
2017 Q4	$11K	Hold	422	–	–	﹤0.01%	215
2017 Q3	$10K	Hold	422	–	–	﹤0.01%	190
2017 Q2	$9K	Hold	422	–	–	﹤0.01%	200
2017 Q1	$7K	Hold	422	–	–	﹤0.01%	236
2016 Q4	$8K	Buy	+422	New	+$8K	﹤0.01%	233